Market Analysis and Insights: Global Pain Management Drugs Market

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

Due to the COVID-19 pandemic, the global Pain Management Drugs market size is estimated to be worth US$ 35360 million in 2022 and is forecast to a readjusted size of US$ 44550 million by 2029 with a CAGR of 3.3% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Generic Opioids accounting for % of the Pain Management Drugs global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospitals segment is altered to an % CAGR throughout this forecast period.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

Global Pain Management Drugs Scope and Market Size

The global Pain Management Drugs market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pain Management Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2029.


Segment by Type


Generic Opioids

Branded Opioids

NSAIDs

Others


Segment by Application


Hospitals

Drugstores

Others

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


GSK

Pfizer

Grunenthal

Sanofi

Bayer

AstraZeneca

Eli Lilly

Endo

Merck

Yunnan Baiyao

Teikoku Seiyaku

Teva

J&J

Assertio Therapeutics

Allergan